Pegylated interferon alfa-2a (PEGASYSTM) and ribavirin combination therapy for chronic hepatitis C: A phase II open-label study
- 30 April 2000
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 118 (4), A950
- https://doi.org/10.1016/s0016-5085(00)85944-2